Questioning the sex-specific differences in the association of smoking on the survival rate of hospitalized COVID-19 patients
Open Access
- 5 August 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0255692
Abstract
In the absence of a universally accepted association between smoking and COVID-19 health outcomes, we investigated this relationship in a representative cohort from one of the world’s highest tobacco consuming regions. This is the first report from the Middle East and North Africa that tackles specifically the association of smoking and COVID-19 mortality while demonstrating a novel sex-discrepancy in the survival rates among patients. Clinical data for 743 hospitalized COVID-19 patients was retrospectively collected from the leading centre for COVID-19 testing and treatment in Lebanon. Logistic regression, Kaplan-Meier survival curves and Cox proportional hazards model adjusted for age and stratified by sex were used to assess the association between the current cigarette smoking status of patients and COVID-19 outcomes. In addition to the high smoking prevalence among our hospitalized COVID-19 patients (42.3%), enrolled smokers tended to have higher reported ICU admissions (28.3% vs 16.6%, p<0.001), longer length of stay in the hospital (12.0 ± 7.8 vs 10.8 days, p<0.001) and higher death incidences as compared to non-smokers (60.5% vs 39.5%, p<0.001). Smokers had an elevated odds ratio for death (OR = 2.3, p<0.001) and for ICU admission (OR = 2.0, p<0.001) which remained significant in a multivariate regression model. Once adjusted for age and stratified by sex, our data revealed that current smoking status reduces survival rate in male patients ([HR] = 1.9 [95% (CI), 1.029–3.616]; p = 0.041) but it does not affect survival outcomes among hospitalized female patients([HR] = 0.79 [95% CI = 0.374–1.689]; p = 0.551). A high smoking prevalence was detected in our hospitalized COVID-19 cohort combined with worse prognosis and higher mortality rate in smoking patients. Our study was the first to highlight potential sex-specific consequences for smoking on COVID-19 outcomes that might further explain the higher vulnerability to death from this disease among men.Keywords
This publication has 29 references indexed in Scilit:
- Female vulnerability to the effects of smoking on health outcomes in older peoplePLOS ONE, 2020
- Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, ChinaClinical Microbiology and Infection, 2020
- Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?Frontiers in Immunology, 2020
- Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)European Journal of Internal Medicine, 2020
- COVID-19 and smoking: A systematic review of the evidenceTobacco Induced Diseases, 2020
- Smoking and Lung Cancer: A Geo-Regional PerspectiveFrontiers in Oncology, 2017
- Sex Differences and Sex Steroids in Lung Health and DiseaseEndocrine Reviews, 2012
- Lung cancer incidence in the arab league countries: risk factors and control.2011
- Sex Differences in Emphysema and Airway Disease in SmokersChest, 2009
- Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population studyEuropean Respiratory Journal, 1997